KLRA

Kailera Therapeutics

• NASDAQ·10/02 20:34

  Oversold Conditions For Kailera Therapeutics (KLRA)

• TipRanks·10/02 12:36

  Seven new option listings on October 2nd

• Seeking Alpha·10/02 08:21

  GLP-1s: Still Early In The Growth Story

• TipRanks·10/01 10:55

  Kailera Therapeutics announces positive results from several presentations

• The Motley Fool·09/30 23:30

  Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy

• TipRanks·09/30 15:20

  Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA) and Immunome (IMNM)

• TipRanks·09/30 11:10

  Kailera announces completion of enrollment in KaiNETIC Phase 3 program

• Benzinga·09/30 11:04

  Kailera Therapeutics Completes Enrollment In KaiNETIC Global Phase 3 Clinical Program; Topline Data Now Expected In Mid-2028

• TipRanks·09/30 09:05

  TD Cowen Sticks to Its Buy Rating for Kailera Therapeutics, Inc. (KLRA)

• Seeking Alpha·09/18 19:02

  Kailera Therapeutics: Hold Due To Need For Progress On Weight Loss Differentiation

• Seeking Alpha·09/17 15:42

  Kailera Therapeutics: An Outside Biotech Bet For The Next GLP-1 Obesity Drug Approval

• Benzinga·09/11 12:49

  Jim Cramer Recommends Buying This Energy Stock, Calling It ‘Very Inexpensive’

• TipRanks·09/07 18:33

  3 Best Stocks With 100%+ Upside to Buy This Week, According to Analysts

• Seeking Alpha·08/27 23:09

  THQ Offers High-Yield Income From Healthcare Stocks (Rating Upgrade)

• NASDAQ·08/16 20:20

  2 GLP-1 Stocks That Could Double Your Money by 2031